Related references
Note: Only part of the references are listed.Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
J. Hao et al.
BRITISH JOURNAL OF CANCER (2010)
Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
Celine Pinheiro et al.
HISTOPATHOLOGY (2010)
Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
Celine Pinheiro et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Expression and Clinical Significance of CD147 in Genitourinary Carcinomas
Zhao-dong Han et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells
Mark G. Slomiany et al.
CANCER RESEARCH (2009)
Characterization of Monocarboxylate Transporters' expression in prostate carcinoma
Nelma Gomes et al.
MICROSCOPY AND MICROANALYSIS (2009)
CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer
Zhao-dong Han et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression
Michele C. Madigan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma
Celine Pinheiro et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer
Wei-de Zhong et al.
ONCOLOGY (2008)
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Celine Pinheiro et al.
VIRCHOWS ARCHIV (2008)
Lung cancer - A comparative study of metabolism related protein expression in cancer cells and tumor associated stroma
Michael I. Koukourakis et al.
CANCER BIOLOGY & THERAPY (2007)
Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231
Shannon M. Gallagher et al.
CANCER RESEARCH (2007)
High incidence of EMMPRIN expression in human tumors
Sabine Riethdorf et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression
Kazuki Nabeshima et al.
PATHOLOGY INTERNATIONAL (2006)
Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia
AA Deora et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4 - The ancillary protein for the insensitive MCT2 is embigin (gp70)
MC Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair
EE Gabison et al.
BIOCHIMIE (2005)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: An in vitro study
SP Mathupala et al.
NEUROSURGERY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
H Izumi et al.
CANCER TREATMENT REVIEWS (2003)
Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system?
GB McClelland et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression
P Kirk et al.
EMBO JOURNAL (2000)
Share Paper
